Tarsus has received a PDUFA date for their TP-03 drug, which they are hoping to bring to market later this year.
Aziz Mottiwala
Advertisement
Articles by Aziz Mottiwala
Aziz Mottiwala, the Chief Commercial Officer at Tarsus Pharmaceuticals, shares a pipeline update.
Advertisement
Latest Updated Articles
AAOpt 2022: What's in the pipeline for TarsusPublished: November 7th 2022 | Updated:
Advertisement
Advertisement
.png "Optometry Times"){kind=logo}
